Physical compatibility of calcium gluconate and magnesium sulfate injections

被引：1

作者：

Beauregard, Natasha ^{[1
]}

Bertrand, Nicolas ^{[1
]}

Dufour, Annick ^{[2
]}

Blaizel, Olivier ^{[2
]}

Leclair, Gregoire ^{[1
]}

机构：

[1] Univ Montreal, Downtown Stn, Montreal, PQ H3C 3J7, Canada

[2] Charles Lemoyne Hosp, Longueuil, PQ, Canada

来源：

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2012年 / 69卷 / 02期

关键词：

D O I：

10.2146/ajhp110342

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：98 / 98

页数：1

共 6 条

[1]

[Anonymous], 2010, NAT FORM

[2] Oxaliplatin-associated neuropathy: A review [J].

Cersosimo, RJ .

ANNALS OF PHARMACOTHERAPY, 2005, 39 (01) :128-135

[3] Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration [J].

Chan, Pak ;

Bishop, Amanda ;

Kuplec, Thomas C. ;

Trissel, Lawrence A. ;

Gole, Dilip ;

Jimidar, Ilias M. ;

Vermeersch, Hans .

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (16) :1545-1551

[4]

De Gramont A, 2005, J CLIN ONCOL S, V23

[5] Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions:: A retrospective study of 161 patients receiving oxaliplatin combined with 5-fluorouracil and leucovorin for advanced colorectal cancer [J].

Gamelin, L ;

Boisdron-Celle, M ;

Delva, R ;

Guérin-Meyer, V ;

Ifrah, N ;

Morel, A ;

Gamelin, E .

CLINICAL CANCER RESEARCH, 2004, 10 (12) :4055-4061

[6]

Hochster HS, 2008, J CLIN ONCOL S, V26

← 1 →